Ausgabe 1/2018
Inhalt (23 Artikel)
Living with Juvenile Idiopathic Arthritis: Parent and Physician Perspectives
Shelly Heath-Watson, Sangeeta Sule
Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases
Gergely Bodis, Victoria Toth, Andreas Schwarting
A Review of Recent Advances Using Tocilizumab in the Treatment of Rheumatic Diseases
Andrea Rubbert-Roth, Daniel E. Furst, Jan Michael Nebesky, Angela Jin, Erhan Berber
Baricitinib in Patients with Rheumatoid Arthritis and an Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs in United States and Rest of World: A Subset Analysis
Alvin F. Wells, Maria Greenwald, John D. Bradley, Jahangir Alam, Vipin Arora, Cynthia E. Kartman
Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland
Rebekah H. Borse, Sumesh Kachroo, Chloe Brown, Eilish McCann, Ralph P. Insinga
Impact of the Adalimumab Patient Support Program on Clinical Outcomes in Ankylosing Spondylitis: Results from the COMPANION Study
Louis Bessette, Gerald Lebovic, Brad Millson, Katia Charland, Krishna Donepudi, Tania Gaetano, Valencia Remple, Martin G. Latour, Sandra Gazel, Marie-Claude Laliberté, Carter Thorne
Quality of Care in Rheumatoid Disease from the Clinician Perspective: A Modified Delphi Panel Approach
Finbar O’Shea, Peter C. Taylor, Gavin Dickie, Andrew Yaworsky, Benjamin Banderas, Sumesh Kachroo
Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison
Peter Nash, Iain B. McInnes, Philip J. Mease, Howard Thom, Matthias Hunger, Andreas Karabis, Kunal Gandhi, Shephard Mpofu, Steffen M. Jugl
Similar Improvements in Patient-Reported Outcomes Among Rheumatoid Arthritis Patients Treated with Two Different Doses of Methotrexate in Combination with Adalimumab: Results From the MUSICA Trial
Gurjit S. Kaeley, Daryl K. MacCarter, Janak R. Goyal, Shufang Liu, Kun Chen, Jennifer Griffith, Hartmut Kupper, Vishvas Garg, Jasmina Kalabic
Safety, Effectiveness, and Treatment Persistence of Golimumab in Elderly Patients with Rheumatoid Arthritis in Real-World Clinical Practice in Japan
Masateru Okazaki, Hisanori Kobayashi, Hirohito Shimizu, Yutaka Ishii, Tsutomu Yajima, Masayoshi Kanbori
Maintenance of Remission with Etanercept–DMARD Combination Therapy Compared with DMARDs Alone in African and Middle Eastern Patients with Active Rheumatoid Arthritis
Hassan Bassiouni, Catherine Elizabeth Spargo, Bonnie Vlahos, Heather E. Jones, Ron Pedersen, Khalid Shirazy
Costs of Disease Relapses Among Individuals with Granulomatosis, with Polyangiitis, or Microscopic Polyangiitis in the United States
Amanda M. Kong, Gilwan Kim, Margaret Michalska, Jennie H. Best
Cost of Depression in Japanese Patients with Rheumatoid Arthritis: Evidence from Administrative Data
Florent Guelfucci, Yuko Kaneko, Jörg Mahlich, Rosarin Sruamsiri
Real-World Treatment Patterns for Golimumab and Concomitant Medications in Japanese Rheumatoid Arthritis Patients
Masateru Okazaki, Hisanori Kobayashi, Yutaka Ishii, Masayoshi Kanbori, Tsutomu Yajima
Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc Analysis
Roy Fleischmann, Jürgen Wollenhaupt, Stanley Cohen, Lisy Wang, Haiyun Fan, Vara Bandi, John Andrews, Liza Takiya, Eustratios Bananis, Michael E. Weinblatt
Examination of Patient-Reported Outcomes in Association with TNF-Inhibitor Treatment Response: Results from a US Observational Cohort Study
Cynthia J. Larmore, Natalie N. Boytsov, Carol L. Gaich, Xiang Zhang, Andre B. Araujo, Sabrina Rebello, Bob A. Salim, George W. Reed, Leslie R. Harrold
Usability and Patient Preference Phase 3 Study of the Sarilumab Pen in Patients with Active Moderate-to-Severe Rheumatoid Arthritis
Alan Kivitz, Lydie Baret-Cormel, Hubert van Hoogstraten, Sheldon Wang, Janie Parrino, Christine Xu, Marina Stanislav
Improvement in Diagnosis and Treat-to-Target Management of Hyperuricemia in Gout: Results from the GEMA-2 Transversal Study on Practice
Fernando Perez Ruiz, Carlos A. Sanchez-Piedra, Jesus T. Sanchez-Costa, Mariano Andrés, Cesar Diaz-Torne, Mercedes Jimenez-Palop, Eugenio De Miguel, Carmen Moragues, Francisca Sivera
A Retrospective Analysis of Corticosteroid Utilization Before Initiation of Biologic DMARDs Among Patients with Rheumatoid Arthritis in the United States
Christina A. Spivey, Jenny Griffith, Cameron Kaplan, Arnold Postlethwaite, Arijit Ganguli, Junling Wang
A Blinded, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Ferric Carboxymaltose in Iron-Deficient Patients with Fibromyalgia
Chad S. Boomershine, Todd A. Koch, David Morris
Worldwide, 3-Year, Post-Marketing Surveillance Experience with Tofacitinib in Rheumatoid Arthritis
Stanley Cohen, Jeffrey R. Curtis, Ryan DeMasi, Yan Chen, Haiyun Fan, Arif Soonasra, Roy Fleischmann
A Case Report of Chikungunya Fever, Rheumatoid Arthritis, and Felty’s Syndrome
José Kennedy Amaral, Robert T. Schoen
A Beacon in the Dark: Canakinumab. A New Therapeutic Perspective in Chronic Tophaceous Gout
Daniela Marotto, Antonella De Santis, Donatella Chessa, Davide Firinu, Stefano Del Giacco